Elitek and metabolic abnormality management Patient Reports February 10, 2012

Elitek Side Effects Report #5288759-5
Elitek side effect was reported by a Pharmacist from UNITED STATES on Mar 30, 2007. Male patient, weighting 6.50 lb, was diagnosed with hyperuricaemia and was treated with Elitek. After drug was administered, patient experienced the following side effects: bradycardia, cardiopulmonary failure, electrolyte imbalance, fluid overload, hyperkalaemia, metabolic abnormality management, oliguria. Elitek dosage: 0.1 MG/KG REPEATED 12 HOURS LATER. During the same period patient was treated with DAUNORUBICIN. Patient was hospitalized. Patient died.